Hypertension:用手机APP**记录心血管生命体征

2018-07-03 MedSci MedSci原创

心血管疾病仍是全球范围内导致死亡和疾病的主要原因。随着对已经资源紧缺的医疗体系的需求日益增长,未来对疾病的预防可能会依赖于对心血管风险因素的非办公室监控。除了体力活动水平和脉搏速度(PWV)等新的心脏生命体征,移动的健康监控设备可监测血压和心率,或可提供有效的解决方案。现需要开发一个精确的并容易扩展的平台。Brian D. Modena等人开发了一定制的智能手机APP,利用移动的健康设备对250位

血管疾病仍是全球范围内导致死亡和疾病的主要原因。随着对已经资源紧缺的医疗体系的需求日益增长,未来对疾病的预防可能会依赖于对心血管风险因素的非办公室监控。除了体力活动水平和脉搏速度(PWV)等新的心脏生命体征,移动的健康监控设备可监测血压和心率,或可提供有效的解决方案。现需要开发一个精确的并容易扩展的平台。
Brian D. Modena等人开发了一定制的智能手机APP,利用移动的健康设备对250位成年受试者的PWV、血压、心率、体力、睡眠和多种生活方式风险因素进行了长达17周的持续监测,在受试期间,受试者无任何特殊训练。

受试者总体满意度高,有73%的受试者可自行测量血压、PWV,间隔时间短于1小时,至少持续14周。研究人群的血压、PWV、心率、体力活动水平、睡眠时间以及与这些测量之间的相互关系,都与在受控环境下进行的研究获得的人口平均值或数值相匹配。

综上所述,本研究展现了在家里运用mHealth技术精确记录PWV和新的心血管生命体征的准确性和简便性。

原始出处:

Brian D. Modena, et al. Advanced and Accurate Mobile Health Tracking Devices Record New Cardiac Vital Signs. Hypertension.July 02,2018.https://doi.org/10.1161/HYPERTENSIONAHA.118.11177

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
    2019-02-03 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
    2018-07-09 大爰

    学习并分享!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1745910, encodeId=af461e45910b0, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Sun Sep 23 14:11:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038935, encodeId=52c020389358f, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu Jul 19 09:11:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727418, encodeId=15f91e274183d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Feb 03 01:11:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330349, encodeId=794833034922, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jul 09 09:17:10 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501308, encodeId=ec711501308db, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Jul 05 12:11:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329045, encodeId=046632904589, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 03 22:13:03 CST 2018, time=2018-07-03, status=1, ipAttribution=)]
    2018-07-03 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

相关资讯

Hypertension:阻塞性睡眠呼吸暂停对降压治疗反应的血压和动脉僵硬度有何影响?

总之,高血压合并OSA患者接受抗高血压治疗与无OSA的患者具有相似的24小时血压和动脉僵硬度。

Stroke:缺血性卒中和卒中亚型早期血压对脑卒中后认知障碍的影响!

由此可见,缺血性卒中早期血压较低或较高均与3个月PSCI风险增加有关。维持收缩压/舒张压在143-158/93-102mmHg有助于减少PSCI的发生。而大动脉硬化亚型和前循环梗死亚型与3个月PSCI风险增加相关。

JAHA:睡眠不足对女性血压和内皮细胞炎症的影响!

由此可见,这些发现提供了直接证据表明常见的但经常被忽视的睡眠障碍,如睡眠质量差和失眠与血压升高和血管炎症有关,即使在没有睡眠不足的情况下。

Hypertension:腺苷受体对血压的影响取决于受体亚型、盐饮食和性别!

腺苷受体对盐敏感性高血压的血压的效应尚不明确。近期有研究人员对盐饮食对敲除A1、A2A或A2B受体()的盐敏感大鼠的动脉血压的效应进行研究。起始时,所有大鼠饮食盐含量为0.3%;随后分组至盐含量4%或8%饮食组,持续2周。与野生型相比,起始血压不受敲除A1或A2B受体影响;但敲除A2A受体(A2AKOs)大鼠的平均血压、收缩压和舒张压均显著比野生型高(p<0.001),且与性别无关。4%的食

J Hypertens:袖带充气对自我测量血压的影响

由此可见,该研究的结果支持自我血压测量过程中会出现升压反应,并在多次血压读数后仍然存在。

J Hypertens:乳制品摄入量与血压之间的关系

由此可见,低脂乳制品摄入与较低的血压相关,特别是低ACR的参与者。包括磷和钙在内的牛奶中富含的营养素可能与BP存在有益的关联。